In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Global petitgrain industry: with a growing significant CAGR in the period 2021-2026
New research report on the Petitgrain Market, covering the market overview, future economic...